Journal of Antimicrobial Chemotherapy (2000) 46, 941-949
© 2000 The British Society for Antimicrobial Chemotherapy
Patterns of phenotypic resistance to the macrolide-lincosamide-ketolide-streptogramin group of antibiotics in staphylococci
Department of Medical Microbiology, Royal Free and University College, Royal Free Campus, London NW3 2PF, UK
Phenotypes of resistance to the macrolide-lincosamide-ketolide-streptogramin (MLKS) group of antibiotics have been determined in 540 clinical isolates of staphylococci (210 Staphylococcus aureus and 330 coagulase-negative species). Results of disc diffusion tests using erythromycin A, oleandomycin, rokitamycin, clindamycin, telithromycin, quinupristin and dalfopristin delineated four main groups corresponding to those defined classically using erythromycin and clindamycin only, but with sub-divisions. Resistance to erythromycin was more common in coagulase-negative strains (56%) than in S. aureus (16%); telithromycin, clindamycin, quinupristin–dalfopristin and rokitamycin were active against >97% of S. aureus strains and >88% of the coagulase-negative strains. The commonest resistance phenotype was ‘inducible MLSB’ (12% in S. aureus, 31% in coagulase-negative strains); this group could be divided in terms of the different inducing abilities of erythromycin and oleandomycin. ‘Constitutive MLSB’ and ‘MS’ phenotypes were more often found in coagulase-negative strains (11 and 13%, respectively) than in S. aureus (2 and 1%). Novel phenotypes were found during the isolation of constitutively resistant mutants from inducible strains, and of resistant mutants from ‘MS’ strains. This extended phenotyping scheme has revealed further complexities and evolutionary possibilities in patterns of resistance to this group of antibiotics.
* Corresponding author. Tel: +44-20-7794-0500; Fax: +44-20-7435-9694; E-mail: j.hamilton-miller{at}rfhsm.ac.uk
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. V. N. O'Sullivan, Y. Cai, F. Kong, X. Zeng, and G. L. Gilbert Influence of Disk Separation Distance on Accuracy of the Disk Approximation Test for Detection of Inducible Clindamycin Resistance in Staphylococcus spp. J. Clin. Microbiol., November 1, 2006; 44(11): 4072 - 4076. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Davis, S. A. Crawford, K. R. Fiebelkorn, and J. H. Jorgensen Induction of Telithromycin Resistance by Erythromycin in Isolates of Macrolide-Resistant Staphylococcus spp. Antimicrob. Agents Chemother., July 1, 2005; 49(7): 3059 - 3061. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Zelazny, M. J. Ferraro, A. Glennen, J. F. Hindler, L. M. Mann, S. Munro, P. R. Murray, L. B. Reller, F. C. Tenover, and J. H. Jorgensen Selection of Strains for Quality Assessment of the Disk Induction Method for Detection of Inducible Clindamycin Resistance in Staphylococci: a CLSI Collaborative Study J. Clin. Microbiol., June 1, 2005; 43(6): 2613 - 2615. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Chesneau, H. Ligeret, N. Hosan-Aghaie, A. Morvan, and E. Dassa Molecular Analysis of Resistance to Streptogramin A Compounds Conferred by the Vga Proteins of Staphylococci Antimicrob. Agents Chemother., March 1, 2005; 49(3): 973 - 980. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. P. Levin, B. Suh, P. Axelrod, A. L. Truant, and T. Fekete Potential Clindamycin Resistance in Clindamycin-Susceptible, Erythromycin-Resistant Staphylococcus aureus: Report of a Clinical Failure Antimicrob. Agents Chemother., March 1, 2005; 49(3): 1222 - 1224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Jorgensen, S. A. Crawford, M. L. McElmeel, and K. R. Fiebelkorn Detection of Inducible Clindamycin Resistance of Staphylococci in Conjunction with Performance of Automated Broth Susceptibility Testing J. Clin. Microbiol., April 1, 2004; 42(4): 1800 - 1802. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Tang, D. E. Low, S. Atkinson, K. Pike, A. Ashi-Sulaiman, A. Simor, S. Richardson, and B. M. Willey Investigation of Staphylococcus aureus Isolates Identified as Erythromycin Intermediate by the Vitek-1 System: Comparison with Results Obtained with the Vitek-2 and Phoenix Systems J. Clin. Microbiol., October 1, 2003; 41(10): 4823 - 4825. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. T. Hamilton-Miller and S. Shah Activity of ketolide ABT-773 (cethromycin) against erythromycin-resistant Streptococcus pneumoniae: correlation with extended MLSK phenotypes J. Antimicrob. Chemother., December 1, 2002; 50(6): 907 - 913. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.-J. Schmitz, J. Petridou, H. Jagusch, N. Astfalk, S. Scheuring, and S. Schwarz Molecular characterization of ketolide-resistant erm(A)-carrying Staphylococcus aureus isolates selected in vitro by telithromycin, ABT-773, quinupristin and clindamycin J. Antimicrob. Chemother., April 1, 2002; 49(4): 611 - 617. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.-J. Schmitz, J. Petridou, D. Milatovic, J. Verhoef, A. C. Fluit, and S. Schwarz In vitro activity of new ketolides against macrolide-susceptible and -resistant Staphylococcus aureus isolates with defined resistance gene status J. Antimicrob. Chemother., March 1, 2002; 49(3): 580 - 582. [Full Text] [PDF]
|
|
|
|
|
|
V. Di Modugno, M. Guerrini, S. Shah, and J. Hamilton-Miller Low level resistance to oleandomycin as a marker of ermA in staphylococci J. Antimicrob. Chemother., February 1, 2002; 49(2): 425 - 427. [Full Text] [PDF]
|
|
|
|
|
|
C. von Eiff and G. Peters Comparative in vitro activity of ABT-773 and two macrolides against staphylococci J. Antimicrob. Chemother., January 1, 2002; 49(1): 189 - 192. [Abstract] [Full Text] [PDF]
|
|